KALA — KALA BIO, Inc.
$0.1901+2.48%
Last close: · regular session
After-hours $0.1940 +2.05% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for KALA in the TickerWise workspace.
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ Global Select
- Employees: 38
- Website: https://www.kalarx.com
Latest SEC filings for KALA
Latest KALA news
- A telehealth platform has generated over $48 million in sales since 2023. KALA Bio may buy it.
- KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception Read article
- Kala Pharmaceuticals Inc (NYSE: KALA) Share Price, KALA Stock News, KALA Share Price & Updates
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.